Application 204223
- Type
- NDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MORPHINE SULFATE | MORPHINE SULFATE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 2MG/ML (2MG/ML) | Yes | Yes |
| 002 | MORPHINE SULFATE | MORPHINE SULFATE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 4MG/ML (4MG/ML) | Yes | Yes |
| 003 | MORPHINE SULFATE | MORPHINE SULFATE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 5MG/ML (5MG/ML) | Yes | Yes |
| 004 | MORPHINE SULFATE | MORPHINE SULFATE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 8MG/ML (8MG/ML) | Yes | Yes |
| 005 | MORPHINE SULFATE | MORPHINE SULFATE | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 10MG/ML (10MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204223-001 | MORPHINE SULFATE | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | |
| N204223-002 | MORPHINE SULFATE | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | |
| N204223-003 | MORPHINE SULFATE | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | |
| N204223-004 | MORPHINE SULFATE | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | |
| N204223-005 | MORPHINE SULFATE | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | |
| N204223-006 | MORPHINE SULFATE | MORPHINE SULFATE | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2026-05-29 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204223-001 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-001 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-001 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-001 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-002 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-002 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-002 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-002 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-003 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-003 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-003 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-003 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-004 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-004 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-004 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-004 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-005 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-005 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-005 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-005 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 1e350fbaab3a… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N204223-001 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-001 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-001 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-001 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-002 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-002 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-002 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-002 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-003 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-003 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-003 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-003 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-004 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-004 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-004 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-004 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-005 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-005 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-005 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204223-005 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Morphine Sulfate | MORPHINE SULFATE | Fresenius Kabi, USA LLC | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | 204223 NDA204223 76045-008 76045-004 76045-005 76045-006 76045-007 |
| Morphine Sulfate | MORPHINE SULFATE | Fresenius Kabi USA, LLC | 582f42e5-444e-4246-af8c-e7e28097c69a | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | 204223 NDA204223 63323-452 63323-454 63323-458 63323-451 63323-455 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 63323-451 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-451 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-451 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-452 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-452 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-452 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-454 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-454 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-454 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-455 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-455 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-455 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-458 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-458 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-458 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-004 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-004 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-004 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-004 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-004 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-004 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-004 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-004 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-005 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-005 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-005 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-005 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-005 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-005 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-005 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-005 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-006 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-006 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-006 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-006 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-006 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-006 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-006 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-006 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-007 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-007 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-007 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-007 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-007 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-007 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-007 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-007 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-008 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-008 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-008 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-008 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-008 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-008 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi USA, LLC | NDA | Current |
| 76045-008 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
| 76045-008 | Morphine Sulfate | Morphine Sulfate | Fresenius Kabi, USA LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 84657 | SUPPL | 2026-01-06 |
| 84576 | SUPPL | 2025-12-29 |
| 77056 | SUPPL | 2023-12-19 |
| 76957 | SUPPL | 2023-12-18 |
| 60502 | SUPPL | 2019-10-09 |
| 60459 | SUPPL | 2019-10-09 |
| 46438 | SUPPL | 2016-12-21 |
| 46432 | SUPPL | 2016-12-21 |
| 24462 | ORIG | 2014-03-06 |
| 22947 | ORIG | 2014-03-06 |
| 10307 | ORIG | 2013-11-06 |
| 19534 | ORIG | 2013-10-31 |